Antiplatelet Therapy to Prevent Stroke in African Americans
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The African-American Antiplatelet Stroke Prevention Study is designed to prevent recurrent
strokes by administration of aspirin or ticlopidine. The study also provides community
information on reducing risk of stroke and recognizing the symptoms of stroke. The study
involves more than 50 participating hospitals located throughout the United States. Study
medication is provided free of charge, and a transportation stipend is available for those in
need.
Phase:
Phase 4
Details
Lead Sponsor:
National Institute of Neurological Disorders and Stroke (NINDS)